During the past decade, S.C Pelican Impex S.R.L conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "S.C Pelican Impex S.R.L" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Biocad" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "S.C Pelican Impex S.R.L" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "S.C Pelican Impex S.R.L" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Colitis, Ulcerative" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "S.C Pelican Impex S.R.L" in a lesser frequency.

Most popular intervention types in "S.C Pelican Impex S.R.L" are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Etrasimod" (4 trials), "Mirikizumab" (3 trials), "Pemetrexed" (2 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "S.C Pelican Impex S.R.L" are 14 trials for "All" genders.

Currently, there are NaN active trials in "S.C Pelican Impex S.R.L". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in S.C Pelican Impex S.R.L, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in S.C Pelican Impex S.R.L, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".